已收录 268922 条政策
 政策提纲
  • 暂无提纲
Reversal of Multidrug Resistance in Human Leukemia K562 by Tamolarizine, a Novel Calcium Antagonist
[摘要] References(15)Cited-By(4)A new type of organic Ca2+ channel blocker, tamolarizine, was examined for its reversing effect on multidrug-resistant tumor cells.Tamolarizine synergistically potentiated the cytotoxicity of doxorubicin for doxorubicin-resistant K562 cells(K562/DXR)at a concentration of 0.1-10μM, but had hardly any synergistic effects in the parental cell line(K562)at the same concentration.Moreover, tamolarizine inhibits the P-glycoprotein pump-efflux activity in a dose-related manner and reduces the expression of the immunoreactive P-glycoprotein in K562/DXR cells as evaluated by cytofluorimetric assay.These results indicate that tamolarizine reverses the multidrug-resistance phenotype through direct interaction with P-gylcoprotein.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词] Doxorubicin-resistant K562 cell;Tamolarizine;Multidrug resistance [时效性] 
   浏览次数:3      统一登录查看全文      激活码登录查看全文